Evidence map›Paper›PMID 35163364›Full record

ArticleInternational journal of molecular sciences2022

Evaluation of Oxidative Stress Biomarkers, Pro-Inflammatory Cytokines, and Histological Changes in Experimental Hypertension, Dyslipidemia, and Type 1 Diabetes Mellitus.

Paul-Mihai Boarescu, Ioana Boarescu, Raluca Maria Pop, Ştefan Horia Roşian, Ioana Corina Bocșan, Vasile Rus, Răzvan Olimpiu Mada, Iulia Diana Popa, Nicholas Neagu, Adriana Elena Bulboacă and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Review
  12. Review
  13. International journal of molecular sciences · 2024
    Article
  14. Open veterinary journal · 2024
    Article
  15. Article
  16. Ginger (Antioxidants (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Clinical medicine insights. Endocrinology and diabetes · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Paul-Mihai BoarescuDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Gheorghe Marinescu Street, No. 23, 400337 Cluj-Napoca, Romania.ORCID 0000-0001-6185-7129
Ioana BoarescuDepartment of Medical Informatics and Biostatistics, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Louis Pasteur Street, No. 6, 400349 Cluj-Napoca, Romania.
Raluca Maria PopDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Gheorghe Marinescu Street, No. 23, 400337 Cluj-Napoca, Romania.ORCID 0000-0003-1899-5977
Ştefan Horia RoşianDepartment of Cardiology-Heart Institute, "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, Calea Moților Street, No. 19-21, 400001 Cluj-Napoca, Romania.ORCID 0000-0002-0570-0642
Ioana Corina BocșanDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Gheorghe Marinescu Street, No. 23, 400337 Cluj-Napoca, Romania.ORCID 0000-0002-3279-5384
Vasile RusDepartment of Cell Biology, Histology and Embryology, University of Agricultural Sciences and Veterinary Medicine, Calea Mănăştur Street, No. 3-5, 400372 Cluj-Napoca, Romania.ORCID 0000-0003-3706-887X
Răzvan Olimpiu Mada"Niculae Stăncioiu" Heart Institute Cluj-Napoca, Calea Moților Street, No. 19-21, 400001 Cluj-Napoca, Romania.
Iulia Diana Popa"Niculae Stăncioiu" Heart Institute Cluj-Napoca, Calea Moților Street, No. 19-21, 400001 Cluj-Napoca, Romania.
Nicholas NeaguFaculty of Medicine, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Luis Pasteur Street, No. 4, 400349 Cluj-Napoca, Romania.
Adriana Elena BulboacăDepartment of Pathophysiology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Victor Babeş Street, No. 2-4, 400012 Cluj-Napoca, Romania.
Anca Dana BuzoianuDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Gheorghe Marinescu Street, No. 23, 400337 Cluj-Napoca, Romania.ORCID 0000-0002-3511-2788
Sorana D BolboacăDepartment of Medical Informatics and Biostatistics, Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Louis Pasteur Street, No. 6, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-2342-4311
Iuliu Hațieganu University of Medicine and Pharmacy · ROUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

Iuliu Hațieganu University of Medicine and Pharmacy POCU/380/6/13/125171.
6 · The paper itself

Abstract

The present study aims to compare the oxidative stress biomarkers, pro-inflammatory cytokines, and histological changes induced by three cardiovascular risk factors, namely, hypertension, dyslipidemia, and type 1 diabetes mellitus. Hypertension was induced with 40 mg/kg body weight (b.w.) of N omega-nitro-L-arginine-methyl (L-NAME) administered orally. Dyslipidemia was induced by the administration of a diet with a high cholesterol (2%) content. Diabetes mellitus was induced by intraperitoneal administration of a single dose of streptozocin (65 mg/kg). Malondialdehyde (MDA) and total oxidative status (TOS) are increased by all three cardiovascular risk factors (up to 207%). The indirect assessment of NO synthesis (NOx) is observed to be reduced after L-NAME administration (43%), and dyslipidemia induction (16%), while type 1 diabetes mellitus is associated with the highest levels of NOx (increased 112%). Hypertension, dyslipidemia, and type 1 diabetes reduced the total antioxidative capacity (TAC) and total thiol (SH) levels (up to 57%). The values of evaluated pro-inflammatory cytokines, tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β), assessed from the ascending aorta were elevated by all three cardiovascular risk factors, with the highest levels induced by type 1 diabetes mellitus (up to 259%). The histopathological examination of the ascending and descending aorta revealed reversible pro-atherogenic changes consisting of the accumulation of lipid droplets in the subendothelial connective tissue on rats with hypertension and dyslipidemia. Irreversible pro-atherogenic changes consisting of a reduction of the specific elasticity of the arteries were observed in rats with type 1 diabetes mellitus. Type 1 diabetes mellitus demonstrates an alteration of the oxidative stress parameters, the elevation of tissue levels of the pro-inflammatory cytokines and causing irreversible pro-atherogenic changes on the aortic wall.

Indexed as

AnimalsBiomarkersCytokinesDiabetes Mellitus, Type 1Diet, High-FatDisease Models, AnimalDyslipidemiasHypertensionMaleMalondialdehydeNG-Nitroarginine Methyl EsterNitric OxideOxidative StressRatsStreptozocinSulfhydryl CompoundsBiomarkersCytokinesMalondialdehydeNG-Nitroarginine Methyl EsterNitric OxideStreptozocinSulfhydryl Compoundsatherosclerosisdyslipidemiahypertensioninflammationoxidative stresstype 1 diabetes mellitus

Identifiers

PMID35163364
PMCPMC8835716
OpenAlexW4210659058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.